Stockreport

VIVUS Announces Tacrolimus Receives Orphan Drug Designation in the European Union for the Treatment of Pulmonary Arterial Hypertension

VIVUS  (VVUS) 
Last vivus earnings: 3/3 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.vivus.com/node/5806
PDF CAMPBELL, CA -- (Marketwired) -- 09/06/17 -- VIVUS, Inc. (NASDAQ: VVUS) (the "Company"), a biopharmaceutical company committed to the development and commercialization o [Read more]